S-ICD is effective in preventing sudden death in arrhythmogenic cardiomyopathy athletes during exercise

Research output: Contribution to journalArticle


Here, we describe the cases of two elite athletes, with a diagnosis of arrhythmogenic cardiomyopathy (ACM), in which a subcutaneous implantable cardioverter defibrillator (S-ICD) has been implanted. Both patients experienced a ventricular tachycardia during exercise and received effective S-ICD shocks that interrupted arrhythmias. This report reveals for the first time that the S-ICD is effective in reverting arrhythmias in ACM patients, even during exercise. Moreover, these cases may confirm that competition/physical activity is associated with ICD shocks.

Original languageEnglish
Pages (from-to)1269-1272
Number of pages4
JournalPACE - Pacing and Clinical Electrophysiology
Issue number9
Publication statusPublished - Sep 1 2019



  • arrhythmogenic cardiomyopathy
  • efficacy
  • elite athletes
  • subcutaneous ICD
  • ventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this